Revenue by source
Sequencing$3.99BCore Illumina$0.00Product$0.00Consumables$0.00Microarray$358.00MServices and Other$0.00Instruments$0.00Service, Other$0.00Other Products$0.00Consolidated Variable Interest Entities$0.00
| Segment | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2025 |
|---|
| Sequencing | - | - | - | - | - | $4.11B | $4.17B | $4.11B | $3.99B |
| Core Illumina | $2.43B | $2.75B | - | - | - | - | - | - | - |
| Product | - | - | $2.75B | $802.00M | $788.00M | - | - | - | - |
| Consumables | - | - | $2.16B | - | - | - | - | - | - |
| Microarray | - | - | - | - | - | $417.00M | $413.00M | $392.00M | $358.00M |
| Services and Other | - | - | $584.00M | - | - | - | - | - | - |
| Instruments | - | - | $569.00M | - | - | - | - | - | - |
| Service, Other | - | - | - | $240.00M | $220.00M | - | - | - | - |
| Other Products | - | - | $24.00M | - | - | - | - | - | - |
| Consolidated Variable Interest Entities | - | $6.00M | - | - | - | - | - | - | - |
Revenue by country
Americas$2.41BEMEA$1.26BUNITED STATES$0.00Asia Pacific$430.00MCHINA$243.00MOther Countries$0.00UNITED KINGDOM$0.00
| Segment | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Americas | - | - | - | - | - | - | - | $1.86B | $1.97B | $1.74B | $2.36B | $2.48B | $2.52B | $2.44B | $2.41B |
| EMEA | - | - | - | - | $527.41M | $553.22M | $632.00M | $851.00M | $933.00M | $886.00M | $1.29B | $1.22B | $1.14B | $1.19B | $1.26B |
| UNITED STATES | $528.72M | $568.44M | $714.66M | $950.70M | $1.21B | $1.29B | $1.51B | - | - | - | - | - | - | - | - |
| Asia Pacific | - | - | $276.44M | $342.70M | $379.58M | $456.38M | $514.00M | $618.00M | $268.00M | $267.00M | $377.00M | $418.00M | $459.00M | $438.00M | $430.00M |
| CHINA | - | - | - | - | - | - | - | - | $372.00M | $342.00M | $502.00M | $472.00M | $384.00M | $308.00M | $243.00M |
| Other Countries | - | - | - | - | $105.41M | $94.60M | $95.00M | - | - | - | - | - | - | - | - |
| UNITED KINGDOM | $67.58M | $81.68M | - | - | - | - | - | - | - | - | - | - | - | - | - |